ArticleAlimentary pharmacology & therapeutics2020

Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors. Authors' reply.

Carlos Taxonera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.